DNA vaccination: The answer to stable, protective T-cell memory?

Current Opinion in Immunology

Volumn 15, Issue 4, 2003, Pages 471-476

  Kirman, Joanna R ^a   Seder, Robert A ^b  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; POLYGLACTIN;

CELL ACTIVITY; CELL FUNCTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CODON; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENCY; HUMAN; HUMORAL IMMUNITY; IN VIVO STUDY; INFECTION; INFECTION PREVENTION; MEMORY CELL; NONHUMAN; REGULATORY MECHANISM; REPLICON; REVIEW; VACCINATION;

EID: 0042905865     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00068-2     Document Type: Review

References (47)

1. Gurunathan S., Klinman D.M., Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18:2000;927-974.
2. Masopust D., Vezys V., Marzo A.L., Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 291:2001;2413-2417.
3. Reinhardt R.L., Khoruts A., Merica R., Zell T., Jenkins M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 410:2001;101-105.
4. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:1999;708-712.
5. Hogan R.J., Zhong W., Usherwood E.J., Cookenham T., Roberts A.D., Woodland D.L. Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J. Exp. Med. 193:2001;981-986.
6. Hu H., Huston G., Duso D., Lepak N., Roman E., Swain S.L. CD4(+) T cell effectors can become memory cells with high efficiency and without further division. Nat. Immunol. 2:2001;705-710.
7. Wu C.Y., Kirman J.R., Rotte M.J., Davey D.F., Perfetto S.P., Rhee E.G., Freidag B.L., Hill B.J., Douek D.C., Seder R.A. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3:2002;852-858 By separating effector cells on the basis of cytokine secretion, and monitoring their survival and location upon transfer into naïve recipients, this paper supports a divergent model for Th1 memory differentiation.
8. Swain S.L., Hu H., Huston G. Class II-independent generation of CD4 memory T cells from effectors. Science. 286:1999;1381-1383.
9. Stobie L., Gurunathan S., Prussin C., Sacks D.L., Glaichenhaus N., Wu C.Y., Seder R.A. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8427-8432.
10. Whitmire J.K., Murali-Krishna K., Altman J., Ahmed R. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements. Philos. Trans. R Soc. Lond. B Biol. Sci. 355:2000;373-379.
11. + T-cell memory. Nat. Med. 7:2001;913-919.
12. Kaech S.M., Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:2001;415-422.
13. Murali-Krishna K., Lau L.L., Sambhara S., Lemonnier F., Altman J., Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science. 286:1999;1377-1381.
14. + T-cell memory determined by clonal burst size. Nature. 369:1994;652-654.
15. Prlic M., Lefrancois L., Jameson S.C. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J. Exp. Med. 195:2002;F49-F52.
16. + cells. J. Exp. Med. 195:2002;1523-1532.
17. Chan K., Lee D.J., Schubert A., Tang C.M., Crain B., Schoenberger S.P., Corr M. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA. J. Immunol. 166:2001;3061-3066.
18. Bourgeois C., Veiga-Fernandes H., Joret A.M., Rocha B., Tanchot C. CD8 lethargy in the absence of CD4 help. Eur. J. Immunol. 32:2002;2199-2207.
19. Belz G.T., Wodarz D., Diaz G., Nowak M.A., Doherty P.C. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J. Virol. 76:2002;12388-12393.
20. + T cells were identified as the suppressive population.
21. Shedlock D.J., Whitmire J.K., Tan J., MacDonald A.S., Ahmed R., Shen H. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J. Immunol. 170:2003;2053-2063.
22. O'Hagan D., Singh M., Ugozzoli M., Wild C., Barnett S., Chen M., Schaefer M., Doe B., Otten G.R., Ulmer J.B. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J. Virol. 75:2001;9037-9043.
23. Tollefsen S., Tjelle T., Schneider J., Harboe M., Wiker H., Hewinson G., Huygen K., Mathiesen I. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine. 20:2002;3370-3378.
24. Maloy K.J., Erdmann I., Basch V., Sierro S., Kramps T.A., Zinkernagel R.M., Oehen S., Kundig T.M. Intralymphatic immunization enhances DNA vaccination. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3299-3303.
25. Moore A.C., Kong W.P., Chakrabarti B.K., Nabel G.J. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. J. Virol. 76:2002;243-250.
26. + T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J. Immunol. 168:2002;562-568.
27. Sasaki S., Amara R.R., Yeow W.S., Pitha P.M., Robinson H.L. Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors. J. Virol. 76:2002;6652-6659.
28. Sasaki S., Amara R.R., Oran A.E., Smith J.M., Robinson H.L. Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat. Biotechnol. 19:2001;543-547.
29. + T cell responses by effects on dendritic cells. J. Immunol. 167:2001;3592-3599.
30. + T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways. J. Immunol. 169:2002;4951-4960.
31. Casimiro D.R., Tang A., Perry H.C., Long R.S., Chen M., Heidecker G.J., Davies M.E., Freed D.C., Persaud N.V., Dubey S.et al. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene. J. Virol. 76:2002;185-194.
32. Leitner W.W., Hwang L.N., DeVeer M.J., Zhou A., Silverman R.H., Williams B.R., Dubensky T.W., Ying H., Restifo N.P. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 9:2003;33-39 The requirement for dsRNA for the function of DNA vaccines encoding the alphavirus replicon was demonstrated in RNase L-deficient mice.
33. + T-cell immunity. J. Virol. 76:2002;3791-3799.
34. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K.et al. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
35. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:1997;3635-3639.
36. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
37. Kojima Y., Xin K.Q., Ooki T., Hamajima K., Oikawa T., Shinoda K., Ozaki T., Hoshino Y., Jounai N., Nakazawa M.et al. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine. 20:2002;2857-2865.
38. Yamada H., Gursel I., Takeshita F., Conover J., Ishii K.J., Gursel M., Takeshita S., Klinman D.M. Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 169:2002;5590-5594.
39. McShane H. Prime-boost immunization strategies for infectious diseases. Curr. Opin. Mol. Ther. 4:2002;23-27.
40. Eo S.K., Gierynska M., Kamar A.A., Rouse B.T. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. J. Immunol. 166:2001;5473-5479.
41. Yang Z.Y., Wyatt L.S., Kong W.P., Moodie Z., Moss B., Nabel G.J. Overcoming immunity to a viral vaccine by DNA priming before vector boosting. J. Virol. 77:2003;799-803.
42. Feng C.G., Palendira U., Demangel C., Spratt J.M., Malin A.S., Britton W.J. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Infect Immun. 69:2001;4174-4176.
43. hi (central memory).
44. + T-cell repertoire of central and effector memory cell populations was examined in the peripheral blood of healthy individuals over a 7 to 19 month period. The repertoires of both populations were largely distinct, implying that these memory subsets had evolved from separate lineages.
45. + T lymphocytes. Nature. 421:2003;852-856.
46. Shedlock D.J., Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 300:2003;337-339.
47. Sun J.C., Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 300:2003;339-342.